Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04559490 · ClinicalTrials.gov registry record
Baby Formula and Health
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 22
- Enrollment target
NCT04559490: Completed study, sponsored by University of Rochester.
NCT04559490 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04559490 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about how different types of carbohydrates used in infant formula may affect a baby's intestines and pancreas.
Primary Outcome
change in blood glucose from fasting to 1 hour post glucose challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-09-16 |
| Est. Completion | 2023-09-16 |
What the finished NCT04559490 record still lists
NCT04559490 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04559490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04559490 about?
NCT04559490 is a clinical study titled "Baby Formula and Health". The purpose of this study is to learn about how different types of carbohydrates used in infant formula may affect a baby's intestines and pancreas.
What is the current status of trial NCT04559490?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2020-09-16. Estimated completion is 2023-09-16.
Who is sponsoring clinical trial NCT04559490?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI